Details
Stereochemistry | RACEMIC |
Molecular Formula | C17H18F3NO |
Molecular Weight | 309.3261 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C2=CC=CC=C2
InChI
InChIKey=RTHCYVBBDHJXIQ-UHFFFAOYSA-N
InChI=1S/C17H18F3NO/c1-21-12-11-16(13-5-3-2-4-6-13)22-15-9-7-14(8-10-15)17(18,19)20/h2-10,16,21H,11-12H2,1H3
Molecular Formula | C17H18F3NO |
Molecular Weight | 309.3261 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:36:36 UTC 2023
by
admin
on
Fri Dec 15 15:36:36 UTC 2023
|
Record UNII |
01K63SUP8D
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
183504
Created by
admin on Fri Dec 15 15:36:36 UTC 2023 , Edited by admin on Fri Dec 15 15:36:36 UTC 2023
|
||
|
NDF-RT |
N0000000109
Created by
admin on Fri Dec 15 15:36:36 UTC 2023 , Edited by admin on Fri Dec 15 15:36:36 UTC 2023
|
||
|
WHO-ATC |
N06AB03
Created by
admin on Fri Dec 15 15:36:36 UTC 2023 , Edited by admin on Fri Dec 15 15:36:36 UTC 2023
|
||
|
EMA VETERINARY ASSESSMENT REPORTS |
RECONCILE [AUTHORIZED]
Created by
admin on Fri Dec 15 15:36:36 UTC 2023 , Edited by admin on Fri Dec 15 15:36:36 UTC 2023
|
||
|
FDA ORPHAN DRUG |
123199
Created by
admin on Fri Dec 15 15:36:36 UTC 2023 , Edited by admin on Fri Dec 15 15:36:36 UTC 2023
|
||
|
LIVERTOX |
NBK548010
Created by
admin on Fri Dec 15 15:36:36 UTC 2023 , Edited by admin on Fri Dec 15 15:36:36 UTC 2023
|
||
|
WHO-ATC |
N06CA03
Created by
admin on Fri Dec 15 15:36:36 UTC 2023 , Edited by admin on Fri Dec 15 15:36:36 UTC 2023
|
||
|
WHO-VATC |
QN06AB03
Created by
admin on Fri Dec 15 15:36:36 UTC 2023 , Edited by admin on Fri Dec 15 15:36:36 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
24.2.1
Created by
admin on Fri Dec 15 15:36:36 UTC 2023 , Edited by admin on Fri Dec 15 15:36:36 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
8.4
Created by
admin on Fri Dec 15 15:36:36 UTC 2023 , Edited by admin on Fri Dec 15 15:36:36 UTC 2023
|
||
|
NCI_THESAURUS |
C94725
Created by
admin on Fri Dec 15 15:36:36 UTC 2023 , Edited by admin on Fri Dec 15 15:36:36 UTC 2023
|
||
|
CFR |
21 CFR 520.980
Created by
admin on Fri Dec 15 15:36:36 UTC 2023 , Edited by admin on Fri Dec 15 15:36:36 UTC 2023
|
||
|
NCI_THESAURUS |
C265
Created by
admin on Fri Dec 15 15:36:36 UTC 2023 , Edited by admin on Fri Dec 15 15:36:36 UTC 2023
|
||
|
NDF-RT |
N0000175696
Created by
admin on Fri Dec 15 15:36:36 UTC 2023 , Edited by admin on Fri Dec 15 15:36:36 UTC 2023
|
||
|
WHO-VATC |
QN06CA03
Created by
admin on Fri Dec 15 15:36:36 UTC 2023 , Edited by admin on Fri Dec 15 15:36:36 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
FLUOXETINE
Created by
admin on Fri Dec 15 15:36:36 UTC 2023 , Edited by admin on Fri Dec 15 15:36:36 UTC 2023
|
PRIMARY | |||
|
m5487
Created by
admin on Fri Dec 15 15:36:36 UTC 2023 , Edited by admin on Fri Dec 15 15:36:36 UTC 2023
|
PRIMARY | Merck Index | ||
|
54910-89-3
Created by
admin on Fri Dec 15 15:36:36 UTC 2023 , Edited by admin on Fri Dec 15 15:36:36 UTC 2023
|
PRIMARY | |||
|
CHEMBL41
Created by
admin on Fri Dec 15 15:36:36 UTC 2023 , Edited by admin on Fri Dec 15 15:36:36 UTC 2023
|
PRIMARY | |||
|
SUB07723MIG
Created by
admin on Fri Dec 15 15:36:36 UTC 2023 , Edited by admin on Fri Dec 15 15:36:36 UTC 2023
|
PRIMARY | |||
|
01K63SUP8D
Created by
admin on Fri Dec 15 15:36:36 UTC 2023 , Edited by admin on Fri Dec 15 15:36:36 UTC 2023
|
PRIMARY | |||
|
01K63SUP8D
Created by
admin on Fri Dec 15 15:36:36 UTC 2023 , Edited by admin on Fri Dec 15 15:36:36 UTC 2023
|
PRIMARY | |||
|
1209
Created by
admin on Fri Dec 15 15:36:36 UTC 2023 , Edited by admin on Fri Dec 15 15:36:36 UTC 2023
|
PRIMARY | |||
|
283480
Created by
admin on Fri Dec 15 15:36:36 UTC 2023 , Edited by admin on Fri Dec 15 15:36:36 UTC 2023
|
PRIMARY | |||
|
4493
Created by
admin on Fri Dec 15 15:36:36 UTC 2023 , Edited by admin on Fri Dec 15 15:36:36 UTC 2023
|
PRIMARY | RxNorm | ||
|
C506
Created by
admin on Fri Dec 15 15:36:36 UTC 2023 , Edited by admin on Fri Dec 15 15:36:36 UTC 2023
|
PRIMARY | |||
|
DTXSID7023067
Created by
admin on Fri Dec 15 15:36:36 UTC 2023 , Edited by admin on Fri Dec 15 15:36:36 UTC 2023
|
PRIMARY | |||
|
203
Created by
admin on Fri Dec 15 15:36:36 UTC 2023 , Edited by admin on Fri Dec 15 15:36:36 UTC 2023
|
PRIMARY | |||
|
5118
Created by
admin on Fri Dec 15 15:36:36 UTC 2023 , Edited by admin on Fri Dec 15 15:36:36 UTC 2023
|
PRIMARY | |||
|
3386
Created by
admin on Fri Dec 15 15:36:36 UTC 2023 , Edited by admin on Fri Dec 15 15:36:36 UTC 2023
|
PRIMARY | |||
|
3883
Created by
admin on Fri Dec 15 15:36:36 UTC 2023 , Edited by admin on Fri Dec 15 15:36:36 UTC 2023
|
PRIMARY | |||
|
DB00472
Created by
admin on Fri Dec 15 15:36:36 UTC 2023 , Edited by admin on Fri Dec 15 15:36:36 UTC 2023
|
PRIMARY | |||
|
D005473
Created by
admin on Fri Dec 15 15:36:36 UTC 2023 , Edited by admin on Fri Dec 15 15:36:36 UTC 2023
|
PRIMARY | |||
|
758685
Created by
admin on Fri Dec 15 15:36:36 UTC 2023 , Edited by admin on Fri Dec 15 15:36:36 UTC 2023
|
PRIMARY | |||
|
Fluoxetine
Created by
admin on Fri Dec 15 15:36:36 UTC 2023 , Edited by admin on Fri Dec 15 15:36:36 UTC 2023
|
PRIMARY | |||
|
100000092819
Created by
admin on Fri Dec 15 15:36:36 UTC 2023 , Edited by admin on Fri Dec 15 15:36:36 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> INHIBITOR | |||
|
TARGET -> INHIBITOR | |||
|
METABOLIC ENZYME -> INHIBITOR | |||
|
SALT/SOLVATE -> PARENT | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
|
||
|
METABOLITE ACTIVE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
MAXIMUM TOLERATED DOSE | TOXICITY |
|
RAPID METABOLIZERS OR THOSE WITH INADEQUATE RESPONSE AFTER 8 WEEKS |
|
||
Tmax | PHARMACOKINETIC |
|
|
|||
Biological Half-life | PHARMACOKINETIC |
|
NORFLUOXETINE PHARMACOKINETIC PHARMACOKINETIC PHARMACOKINETIC |
|
||